Dr. Dar-Jen Hsieh is CEO and founder of ACRO Biomedical Co., Ltd. Dr. Hsieh received his Ph. D in Cell & Molecular Biology from SUNY at Buffalo, and after working as an associate professor at Kaohsiung Medical University, he switched the career path to join the industry, and has been in biotech field for more than twenty years. Dr. Hsieh was CEO of Sunmax Biotechnology and PRIT Biotech, a Director of Business Development at Animal Technology Institute Taiwan
, and also a Deputy CEO of Institute for biotechnology and medicine industry (IBMI) in Taiwan. In 2014, Dr. Hsieh started ACRO Biomedical Co., Ltd.- the company using the core technology supercritical CO2 to process decellularized tissue scaffolds that can applied to medical and research uses in the field of tissue engineering and regenerative medicine.